Johnson & Johnson (J&J) will become more competitive in personal care after the carve out of its consumer health business, particularly if it invests in personalised and premium NPD, an analyst says.
Personal care titan Johnson & Johnson (J&J) will split out its consumer health business to create a new publicly traded company, part of its wider plan to pursue more targeted growth strategies.
![Johnson & Johnson's decision to spin-off its consumer health unit will create space for dedicated R&D investment in personal care, benefitting consumers [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/article/2021/11/22/johnson-johnson-consumer-health-company-to-become-premium-competitive-business-says-globaldata/13032125-1-eng-GB/Johnson-Johnson-Consumer-Health-Company-to-become-premium-competitive-business-says-GlobalData.jpg)
![Johnson & Johnson plans to complete the carve-out of a standalone Consumer Health business by the end of 2022 [Getty Images]](/var/wrbm_gb_food_pharma/storage/images/_aliases/news_teaser_medium/publications/cosmetics/cosmeticsdesign-europe.com/headlines/business-financial/johnson-johnson-splits-consumer-health-business-to-drive-growth/13016725-1-eng-GB/Johnson-Johnson-splits-consumer-health-business-to-drive-growth.jpg)
